US 11,813,375 B2
Therapeutic agent for solid cancer
Junichi Shimada, Kyoto (JP)
Assigned to YANCHERS INC., Kyoto (JP)
Appl. No. 16/315,756
Filed by YANCHERS INC., Kyoto (JP)
PCT Filed Jul. 7, 2017, PCT No. PCT/JP2017/025044
§ 371(c)(1), (2) Date Jan. 7, 2019,
PCT Pub. No. WO2018/008761, PCT Pub. Date Jan. 11, 2018.
Claims priority of application No. 2016-153227 (JP), filed on Jul. 8, 2016.
Prior Publication US 2019/0314545 A1, Oct. 17, 2019
Int. Cl. A61K 9/00 (2006.01); A61L 24/06 (2006.01); A61K 31/695 (2006.01); A61K 31/785 (2006.01); A61K 49/04 (2006.01)
CPC A61L 24/06 (2013.01) [A61K 31/695 (2013.01); A61K 31/785 (2013.01); A61K 49/0438 (2013.01); A61L 2400/06 (2013.01)] 10 Claims
OG exemplary drawing
 
1. A method of killing solid cancer cells or inhibiting growth of solid cancer cells, which comprises injecting an effective amount of a liquid composition containing as an active component an ethoxy-containing compound, which undergoes a polycondensation reaction in a cellular tissue after injection, into a solid cancer, wherein the liquid composition is injected in an amount effective to kill solid cancer cells or inhibit growth of solid cancer cells in said tissue in said patient, and wherein said liquid composition further contains a transition metal ethoxide.